Literature DB >> 24239206

Biomarker for high-risk patients with stage II colon cancer.

Toshiaki Watanabe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24239206     DOI： 10.1016/S1470-2045(13)70527-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Zinc-α-2-glycoprotein: a candidate biomarker for colon cancer diagnosis in Chinese population.

Authors:  Yingming Xue; Fudong Yu; Dongwang Yan; Feifei Cui; Huamei Tang; Xiaoliang Wang; Jian Chen; Huijun Lu; Senlin Zhao; Zhihai Peng
Journal:  Int J Mol Sci       Date:  2014-12-30       Impact factor: 5.923

2.  miR-1260b is a Potential Prognostic Biomarker in Colorectal Cancer.

Authors:  Deng-Rui Liu; Quan-Lin Guan; Ming-Tai Gao; Lei Jiang; Hong-Xia Kang
Journal:  Med Sci Monit       Date:  2016-07-11

3.  Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.

Authors:  Jialing Zhang; Bin Yan; Stephan Stanislaw Späth; Hu Qun; Shaleeka Cornelius; Daogang Guan; Jiaofang Shao; Koichi Hagiwara; Carter Van Waes; Zhong Chen; Xiulan Su; Yongyi Bi
Journal:  Cell Biosci       Date:  2015-09-17       Impact factor: 7.133

4.  MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1.

Authors:  Jun Zhao; Jingjie Cao; Lurong Zhou; Yunyi Du; Xiaoling Zhang; Bo Yang; Yangjun Gao; Yu Wang; Ning Ma; Wei Yang
Journal:  Oncol Lett       Date:  2018-08-14       Impact factor: 2.967
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.